Clinical impact of preoperative liver MRI in the evaluation of synchronous liver metastasis of colon cancer
- 309 Downloads
To investigate whether additional MRI including gadoxetic acid enhancement is associated with survival rate (SR) in patients with synchronous liver metastasis of colon cancer (sCLM), compared with patients assessed only with CT.
Fifty-two patients underwent only CT (CT group) and 65 underwent additional MRI (CT+MRI group) for preoperative work-up of sCLM. In the CT+MRI group, the discrepancy between CT and MRI was analyzed. The 5-year SR was compared between the groups, and affecting factors were investigated. The inverse probability treatment weighting analysis (IPTW) adjusted by propensity scores was performed.
In the CT+MRI group, 44 (67.7%) showed a discrepancy in the number of sCLMs between CT and MRI. MRI detected 39 additional sCLMs initially missed on CT in 26 patients. The number of detected sCLMs was better correlated with the pathologic findings in the CT+MRI group than in the CT group (p = 0.008). The estimated 5-year SR in the CT+MRI group was 70.8%, while that in the CT group was 48.1%. On adjusted multivariate analyses after the IPTW, the CT+MRI group showed a significantly lower risk of overall mortality than the CT group.
Additional preoperative evaluation by MRI allowed us to more precisely detect sCLM and was associated with a better SR.
• CT+MRI group showed significantly higher 5-year survival rates than CT group.
• CT+MRI group was an independent prognostic factor of overall mortality.
• MRI facilitates more accurate detection and better lesion characterization.
• MRI selected better candidates for curative treatment.
• The benefits of MRI were reflected by better survival.
KeywordsColonic neoplasms Neoplasm metastasis Liver Magnetic resonance imaging Multidetector computed tomography
Inverse probability of treatment weighting
Synchronous liver metastasis of colon cancer
The authors state that this work has not received any funding.
Compliance with ethical standards
The scientific guarantor of this publication is So Yeon Kim.
Conflict of interest
The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.
Statistics and biometry
One of the authors has significant statistical expertise.
Written informed consent was waived by the institutional review board.
Institutional review board approval was obtained.
• case-control study
• performed at one institution
- 5.National Comprehensive Cancer Network (2015) Clinical practice guidelines in oncology, colon cancer, Version 3. https://www.nccn.org/professionals/physician_gls/pdf/colon.pdf. Accessed 14 Mar 2018
- 9.Vreugdenburg TD, Ma N, Duncan JK, Riitano D, Cameron AL, Maddern GJ (2016) Comparative diagnostic accuracy of hepatocyte-specific gadoxetic acid (Gd-EOB-DTPA) enhanced MR imaging and contrast enhanced CT for the detection of liver metastases: a systematic review and meta-analysis. Int J Colorectal Dis 31:1739–1749CrossRefGoogle Scholar
- 12.Kim HJ, Lee SS, Byun JH et al (2015) Incremental value of liver MR imaging in patients with potentially curable colorectal hepatic metastasis detected at CT: a prospective comparison of diffusion-weighted imaging, gadoxetic acid-enhanced MR imaging, and a combination of both MR techniques. Radiology 274:712–722CrossRefGoogle Scholar
- 13.Sofue K, Tsurusaki M, Tokue H, Arai Y, Sugimura K (2011) Gd-EOB-DTPA-enhanced 3.0 T MR imaging: quantitative and qualitative comparison of hepatocyte-phase images obtained 10 min and 20 min after injection for the detection of liver metastases from colorectal carcinoma. Eur Radiol 21:2336–2343CrossRefGoogle Scholar